Skye Bioscience Inc [NASDAQ: SKYE] surged by $703887.84 during the normal trading session on while it closed the day at $703890.0.
Skye Bioscience Inc stock has also gained 40.00% of its value over the past 7 days. However, SKYE stock has inclined by 27.56% in the 3 months of the year. Over the past six months meanwhile, it has lost -11.69% and lost -69.82% year-on date.
The market cap for SKYE stock reached $88.93 million, with 30.97 million shares outstanding and 17.86 million shares in the current float. Compared to the average trading volume of 703.89K shares, SKYE reached a trading volume of 13617894 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Skye Bioscience Inc [SKYE]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SKYE shares is $16.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SKYE stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Skye Bioscience Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on February 28, 2025. While these analysts kept the previous recommendation, Scotiabank raised their target price to Sector Outperform. The new note on the price target was released on September 30, 2024, representing the official price target for Skye Bioscience Inc stock. Previously, the target price had yet another raise to $15, while JMP Securities analysts kept a Mkt Outperform rating on SKYE stock.
The Price to Book ratio for the last quarter was 1.50, with the Price to Cash per share for the same quarter was set at 1.91.
SKYE stock trade performance evaluation
Skye Bioscience Inc [SKYE] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 40.00. With this latest performance, SKYE shares gained by 29.86% in over the last four-week period, additionally sinking by -11.69% over the last 6 months – not to mention a rise of 1.41% in the past year of trading.
Skye Bioscience Inc [SKYE]: An insightful look at the core fundamentals
Return on Equity for this stock declined to -40.91%, with Return on Assets sitting at -40.91%.
Skye Bioscience Inc [SKYE]: Institutional Ownership
The top three institutional holders of SKYE stocks are: 5AM VENTURE MANAGEMENT, LLC with ownership of 10.18 million shares, which is approximately 26.3245%. VERSANT VENTURE MANAGEMENT, LLC, holding 2.01 million shares of the stock with an approximate value of $$16.08 million in SKYE stocks shares; and VERSANT VENTURE MANAGEMENT, LLC, currently with $$10.81 million in SKYE stock with ownership which is approximately 3.4914%.
